• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境中的调节性 T 细胞发育。

Regulatory T-cell development in the tumor microenvironment.

机构信息

Division of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center, Tokyo, Japan.

Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Eur J Immunol. 2022 Aug;52(8):1216-1227. doi: 10.1002/eji.202149358. Epub 2022 Jul 25.

DOI:10.1002/eji.202149358
PMID:35879813
Abstract

Regulatory T (Treg) cells are required for maintaining self-tolerance and preventing the development of autoimmune diseases. However, Treg cells are abundant in tumors and suppress antitumor immunity, contributing to tumor development and growth. Thus, the selective deletion of tumor-infiltrating Treg cells is important for successful Treg cell-targeted therapies, providing effective antitumor immunity without inducing deleterious autoimmune disorders. Advancements in sequencing technologies have exposed the diversity and heterogeneity of human Treg cells during activation and differentiation, further emphasizing the importance of understanding tumor-infiltrating Treg cells for the development of Treg cell-targeted therapies. This review provides an overview of the classification and function of Treg cells and summarizes recent knowledge on the activation and differentiation of Treg cells in the tumor microenvironment.

摘要

调节性 T(Treg)细胞对于维持自身耐受和防止自身免疫性疾病的发展是必需的。然而,Treg 细胞在肿瘤中大量存在,并抑制抗肿瘤免疫,促进肿瘤的发生和生长。因此,选择性地删除肿瘤浸润性 Treg 细胞对于成功的 Treg 细胞靶向治疗非常重要,它可以提供有效的抗肿瘤免疫,而不会引起有害的自身免疫性疾病。测序技术的进步揭示了人类 Treg 细胞在激活和分化过程中的多样性和异质性,进一步强调了了解肿瘤浸润性 Treg 细胞对于开发 Treg 细胞靶向治疗的重要性。本综述概述了 Treg 细胞的分类和功能,并总结了最近关于 Treg 细胞在肿瘤微环境中的激活和分化的知识。

相似文献

1
Regulatory T-cell development in the tumor microenvironment.肿瘤微环境中的调节性 T 细胞发育。
Eur J Immunol. 2022 Aug;52(8):1216-1227. doi: 10.1002/eji.202149358. Epub 2022 Jul 25.
2
Phenotypic and Functional Properties of Tumor-Infiltrating Regulatory T Cells.肿瘤浸润调节性 T 细胞的表型和功能特性。
Mediators Inflamm. 2017;2017:5458178. doi: 10.1155/2017/5458178. Epub 2017 Dec 31.
3
Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity.靶向调节性 T 细胞中的 Cdc42 GTPase 释放抗肿瘤 T 细胞免疫。
J Immunother Cancer. 2022 Nov;10(11). doi: 10.1136/jitc-2022-004806.
4
Significance of regulatory T cells in cancer immunology and immunotherapy.调节性T细胞在癌症免疫学和免疫治疗中的意义。
Exp Dermatol. 2023 Mar;32(3):256-263. doi: 10.1111/exd.14721. Epub 2022 Dec 12.
5
Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.结直肠癌浸润调节性 T 细胞:功能异质性、代谢适应及治疗靶点。
Front Immunol. 2022 Jul 8;13:903564. doi: 10.3389/fimmu.2022.903564. eCollection 2022.
6
Role of CD4CD25FOXP3 T cells on tumor immunity.CD4CD25FOXP3+T 细胞在肿瘤免疫中的作用。
Immunol Med. 2022 Jun;45(2):94-107. doi: 10.1080/25785826.2021.1975228. Epub 2021 Sep 8.
7
Targeting regulatory T cells in tumors.靶向肿瘤中的调节性T细胞。
FEBS J. 2016 Jul;283(14):2731-48. doi: 10.1111/febs.13656. Epub 2016 Mar 1.
8
Remodeling of the tumor microenvironment via disrupting Blimp1 effector Treg activity augments response to anti-PD-1 blockade.通过破坏 Blimp1 效应性 Treg 活性重塑肿瘤微环境可增强对抗 PD-1 封锁的反应。
Mol Cancer. 2021 Nov 20;20(1):150. doi: 10.1186/s12943-021-01450-3.
9
BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors.BATF通过表观遗传和转录调控人类肿瘤中调节性T细胞的激活程序。
Sci Immunol. 2022 Oct 14;7(76):eabk0957. doi: 10.1126/sciimmunol.abk0957. Epub 2022 Oct 7.
10
Tumor resident regulatory T cells.肿瘤驻留调节性 T 细胞。
Semin Immunol. 2021 Feb;52:101476. doi: 10.1016/j.smim.2021.101476. Epub 2021 Apr 24.

引用本文的文献

1
Revisiting Tregs in cancer and beyond: immunological control and therapeutic potential.重新审视癌症及其他领域中的调节性T细胞:免疫控制与治疗潜力
Front Immunol. 2025 Sep 1;16:1581093. doi: 10.3389/fimmu.2025.1581093. eCollection 2025.
2
A high proportion of CD38 (high) CD16 (low) NK cells in colorectal cancer can interrupt immune surveillance and favor tumor growth.结直肠癌中高比例的CD38(高表达)CD16(低表达)自然杀伤细胞会破坏免疫监视并促进肿瘤生长。
Cancer Immunol Immunother. 2025 Jul 12;74(8):263. doi: 10.1007/s00262-025-04044-w.
3
Extracellular Vesicles and PD-L1-A Review of Complex Immunoregulatory Properties and Clinical Importance.
细胞外囊泡与程序性死亡受体1配体——复杂免疫调节特性及临床重要性综述
Biomedicines. 2025 May 31;13(6):1356. doi: 10.3390/biomedicines13061356.
4
Regulatory T Cell in Kidney Transplant: The Future of Cell Therapy?肾移植中的调节性T细胞:细胞治疗的未来?
Antibodies (Basel). 2025 Jun 17;14(2):49. doi: 10.3390/antib14020049.
5
Gut Microbiota Reshapes the Tumor Microenvironment and Affects the Efficacy of Colorectal Cancer Immunotherapy.肠道微生物群重塑肿瘤微环境并影响结直肠癌免疫治疗的疗效。
Cancer Med. 2025 Jun;14(12):e70994. doi: 10.1002/cam4.70994.
6
Polyvalent folate receptor-targeting chimeras for degradation of membrane proteins.用于降解膜蛋白的多价叶酸受体靶向嵌合体。
Nat Chem Biol. 2025 Jun 13. doi: 10.1038/s41589-025-01924-1.
7
Exploring the immune environment of glioblastoma through single-cell RNA sequencing in humanized mouse models.通过人源化小鼠模型中的单细胞RNA测序探索胶质母细胞瘤的免疫环境。
bioRxiv. 2025 May 22:2025.05.17.654526. doi: 10.1101/2025.05.17.654526.
8
C3-Liposome Delivery of MUC1 Peptide and TLR Agonists Enhances Adaptive Immunity and Results in Sex-Based Tumor Growth Differences.C3脂质体递送MUC1肽和TLR激动剂可增强适应性免疫并导致基于性别的肿瘤生长差异。
Pharmaceutics. 2025 Apr 3;17(4):468. doi: 10.3390/pharmaceutics17040468.
9
Development and validation of a prognostic model based on disulfidptosis-related ferroptosis genes: and as biomarkers for predicting prognosis in colon cancer.基于二硫键介导的铁死亡相关基因的预后模型的构建与验证:以 和 作为预测结肠癌预后的生物标志物
Transl Cancer Res. 2025 Jan 31;14(1):159-178. doi: 10.21037/tcr-24-1177. Epub 2025 Jan 20.
10
Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages.持续抑制集落刺激因子1受体(CSF1R)信号传导可通过抑制肿瘤相关巨噬细胞增强抗肿瘤免疫力。
JCI Insight. 2025 Jan 9;10(1):e178146. doi: 10.1172/jci.insight.178146.